With the recent developments in organ-on-a-chip (OC) there will be no requirement for experiments on animals in the near future. An organ-on-a-chip (OC) is a multi-channel 3-D microfluidic cell culture chip which imitates the activities, mechanics and physiological response of the organs and organ systems. It is a type of artificial organ.
The United States Food and Drug Administration (FDA) declared that they will start to work in cooperation with the Emulate Inc. Company which studies on organs-on-chips (OC) technology. Emulate Inc. is a private company that creates living products to understand how diseases, medicines, chemicals, and foods affect human health. After this announcement, it was started to be talked that experiments on the animals may be complicated. It is known that every year just in Europe, more than 11.5 million animals lost their lives during the experiments, and most of them are damaged due to drugs tested on them.
Developing organ technology on a chip was firstly produced by the American initiative Emulate Inc. With the development of such a technology, scientific studies about protection of human health will be done to without damaging animals. In organ-on-a-chip (OC) technology, each chip, which is approximately in the size of a thumb, has channels filled with living human cells and they can stimulate the functions of different organs. The Emulate Company states that they can follow the interaction between the organ and the drug. The firm said that experiments on animals would not have to be carried out with the start of implementation of organ-on-a-chip (OC) technology. The drug experiments that take very lon periods could be completed in short times. The FDA and Emulate are planning to begin producing chips with animal cells that will allow them to observe how animals will react to drugs.